Cardiac myxoma following transcatheter closure of an atrial septal defect.
Saif Sami Al-ModhafferAli Abdulamir MohammedOkba F AhmedFahmi Hussein KakamadDana H Mohammed SaeedHawbash M RahimJihad Ibrahim HamaHemin S MohammedShvan H MohammedPublished in: Proceedings (Baylor University. Medical Center) (2024)
To date, no significant association has been reported between atrial septal defects (ASD) and cardiac myxomas. This study reports a 56-year-old woman with cardiac myxoma following transcatheter closure of ASD. She presented with a 3-month history of recurrent dizziness, vertigo, palpitations, and generalized weakness after undergoing ASD occlusion a year earlier. Echocardiography and cardiac computed tomography scans identified a large, mobile mass (7.2 cm × 2.8 cm) in the left atrium, protruding through the mitral valve. The patient underwent median sternotomy and pericardiotomy, and the histopathological examination confirmed the diagnosis of atrial myxoma. The current case illustrates the challenges in determining whether an atrial mass is a benign myxoma or a dangerous thrombus. While there is no definitive link between the implantation of an ASD closure device and the formation of a myxoma, the emergence of this tumor is a potential occurrence.
Keyphrases
- autism spectrum disorder
- left ventricular
- computed tomography
- left atrial
- mitral valve
- atrial fibrillation
- attention deficit hyperactivity disorder
- catheter ablation
- intellectual disability
- magnetic resonance imaging
- risk assessment
- hypertrophic cardiomyopathy
- heart failure
- emergency department
- squamous cell carcinoma
- case report
- radiation therapy
- climate change
- pulmonary embolism
- contrast enhanced
- working memory
- locally advanced
- coronary artery disease
- human health
- dual energy
- ejection fraction
- rectal cancer